MSB 1.34% $1.51 mesoblast limited

Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA, page-1071

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,942 Posts.
    lightbulb Created with Sketch. 499
    I've got a whisper for ya.

    I heard that the FDA suggested there is sufficient data for approval and that the company intends to file this quarter and expects a 2-month turn around.

    Don't remember where I heard that.... Maybe it was in an article or an announcement or 2.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.51
Change
0.020(1.34%)
Mkt cap ! $1.724B
Open High Low Value Volume
$1.57 $1.58 $1.41 $18.15M 12.09M

Buyers (Bids)

No. Vol. Price($)
1 3418 $1.50
 

Sellers (Offers)

Price($) Vol. No.
$1.51 24361 5
View Market Depth
Last trade - 16.10pm 07/10/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.